The power of personalized insights
While the three leads are representing different directions, these leads are not orthogonal between each other, are not collected according to "Frank" lead system, and do not represent a vectorcardiograph.
Simplifying access to intelligent and actionable 12-lead ECGs*
HeartBeam's groundbreaking approach offers a holistic view of heart health by capturing the heart's electrical activity from three distinct directions for actionable heart insights. This unique approach delivers exceptional data fidelity through a portable, cable-free device that can be used by patients wherever they are when symptoms occur to capture signals without the need for trained professionals.
In the future, HeartBeam plans to synthesize the signals into a 12-lead ECG using a personalized transformation matrix. The ease of use will simplify access and shorten the time to receive valuable 12-lead ECG results, especially upon symptom onset, when minutes matter the most.
Additionally, by leveraging artificial intelligence (AI) to analyze the data-rich signals, HeartBeam plans to improve diagnostic accuracy, track cardiac trends over time, and detect subtle changes that could signal early warning signs. Through the power of AI, HeartBeam has the potential to deliver earlier and more precise management of heart health.
The concept for HeartBeam’s technology was created by Dr. Branislav Vajdic, the co-inventor of flash memory, in collaboration with a Harvard-Beth Israel cardiologist and two nuclear physicists. The technology is well protected with 13 US patents and can be used as a platform technology with broad applications including use in extended wear patches, watches, continuous monitoring systems and with deep learning solutions.
*12-lead synthesis software not cleared by the FDA. Not available for sale in the United States.
In the future, HeartBeam plans to synthesize the signals into a 12-lead ECG using a personalized transformation matrix. The ease of use will simplify access and shorten the time to receive valuable 12-lead ECG results, especially upon symptom onset, when minutes matter the most.
Additionally, by leveraging artificial intelligence (AI) to analyze the data-rich signals, HeartBeam plans to improve diagnostic accuracy, track cardiac trends over time, and detect subtle changes that could signal early warning signs. Through the power of AI, HeartBeam has the potential to deliver earlier and more precise management of heart health.
The concept for HeartBeam’s technology was created by Dr. Branislav Vajdic, the co-inventor of flash memory, in collaboration with a Harvard-Beth Israel cardiologist and two nuclear physicists. The technology is well protected with 13 US patents and can be used as a platform technology with broad applications including use in extended wear patches, watches, continuous monitoring systems and with deep learning solutions.
*12-lead synthesis software not cleared by the FDA. Not available for sale in the United States.
The Future of Cardiac Care
By applying artificial intelligence (AI) to data-rich signals, HeartBeam will be able to provide physicians with unprecedented diagnostic and prognostic insights, including:
Detection of complex arrhythmias and heart attacks*
Personalized cardiac insights through multiple readings captured over time
Predict declining cardiac health and manage chronic conditions
Replace 12-lead ECGs as standard of care†
*Ischemia product not cleared by FDA. Not available for sale in the United States.
†12-lead synthesis software not cleared by the FDA. Not available for sale in the United States
†12-lead synthesis software not cleared by the FDA. Not available for sale in the United States
Heart Attack Detection*
A study published in JACC: Advances7 comparing HeartBeam’s technology to standard 12-lead ECGs found that HeartBeam is:
Equivalent to 12-lead ECG in identifying coronary occlusions
Highly accurate (AUC)
*Ischemia product not cleared by FDA. Not available for sale in the United States.
